Lab tests point to genes that brain tumor cells need to survive
Original title: DDRKOL: A Focused CRISPR Library for Systematic Identification of DNA Damage Response Dependencies in Glioblastoma
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done in lab cells and in mice.
The short version
In lab tests, switching off one gene slowed brain tumor growth in mice.
What was studied. Scientists built a tool to switch off 819 DNA repair genes, one at a time. They tested it in two glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cell lines, in tumor cells from patients, and in mice.
What they found. The tests found 20 repair genes that both cell lines needed. Four stood out: TOP2A, CDK1, XRCC6, and RAD21. Switching off any of these killed cells and slowed growth in tumor cells from patients. In mice, switching off TOP2A stopped the tumor from growing, and the mice lived longer.
What this means, and what it doesn't
What it could mean: These genes may be good targets for new drugs someday. Doctors cannot use any of this in care today. For now it shows researchers where to look next.
What it doesn't mean: This is not a treatment, and it is not a cure. The work was done in cells in a dish and in mice. No person was treated in this study. Many lab findings never work the same way in people. It would take years of testing to know if this helps patients.
Source: bioRxiv (preprint), September 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.